This is also being kept artificially low due to making you go through a broker to fill an order. Makes it hard for pump schemes. I would get out to the Aryc board and start promoting this they have a good collective group of biotech investors. Not bad investors but they’re investing in hope and dreams. We have actual growth. Hit the breakout boards as well. I’m not however worried about this being slow because when the volume comes in it’s going to jump. I’m just slowly increasing my position here without spiking interest. But over the last year I’ve got about what I want so promote away!!
Wound Management Technologies, Inc., a Texas corporation doing business as WNDM Medical Inc. (“WNDM”), entered into definitive agreements, effective August 28, 2018, to transfer its current operations that market its principal product, CellerateRX ® Activated Collagen ® , to a newly formed limited liability company, Cellerate, LLC (“Cellerate”) in which WNDM holds a 50% ownership interest. The remaining 50% ownership interest is held by CellerateRX, LLC (“CGI”), which is owned indirectly by The Catalyst Group, a middle market private equity firm with offices in Houston and Austin, Texas. Cellerate will conduct operations with an exclusive sublicense to distribute CellerateRX ® Activated Collagen® Adjuvant into the wound care and surgical markets in the United States, Canada and Mexico
News 
Market Data 
Discover 
